Aberrant retinal blood flow is a hallmark of various retinopathies and may be a causative factor in the pathology associated with these conditions. We examined the effects of pulsatile flow on bovine retinal endothelial cell (BREC) and bovine retinal pericyte (BRP) apoptosis and proliferation.
Introduction
Mechanical forces associated with blood flow play an important role in maintaining vessel structure and function. Vascular endothelial cells (ECs), which provide an interface between blood and the vessel wall, are constantly subjected to blood flow-induced shear stress. Although ECs are the major recipient of shear stress, cyclic strain due to the pulsatile nature of blood flow exerts itself on 'both' the endothelium and the mural cell layer. Both forces have been shown to modulate local auto-regulation of vessel tone via the abluminal release of factors from ECs, thus causing dilation or constriction of the underlying smooth muscle or pericyte cell layer. 1 Microvascular ECs regulate vessel tone via the vasodilators nitric oxide (NO) and prostacyclin (PGI 2 ) and vasoconstrictors such as endothelin-1 (ET-1). One of the earliest events occurring in ECs placed under increased fluid flow is the activation of endothelial nitric oxide synthase (eNOS) by phosphorylation at several sites and the subsequent release of NO. Reductions in the bioavailability of NO, leading to impaired vasodilation, are associated risk factors for atherosclerosis, diabetes, and hypertension. Production of the vasodilator PGI 2 is controlled by the enzyme cyclooxygenase (COX), which catalyses the formation of prostaglandins and thromboxanes from arachidonic acid. COX comprises two isoenzymes: COX-1, which is constitutively expressed, and COX-2, which is an inducible enzyme with expression that is regulated differently among cell types. Counterbalancing these vasodilatory effects of NO and PGI 2 is the potent vasoconstrictor ET-1, which signals via two G protein-coupled receptors: ET-A and ET-B. ET-A receptors are found on mural cells, whereas ET-B receptors are found on both ECs and mural cells. Binding of ET-1 to ET-A receptors results in vasoconstriction, cell growth, and cell adhesion; however, binding of the same peptide to ET-B receptors on ECs causes vasodilation by stimulating the release of NO and PGI 2 . 2 Auto-regulation of the retinal blood supply is required to maintain perfusion of the neural retina, since the retinal vasculature lacks both autonomic innervation and precapillary smooth muscle sphincters, which control local blood supply in most other tissues. Aberrant retinal blood flow (RBF) has been reported in high-tension glaucoma (HTG), normal-tension glaucoma (NTG), and diabetic retinopathy (DR) and may be a causative factor of the vascular remodelling occurring in each of these pathologies. 3 -6 Vasospasm of retinal vessels and a generalized peripheral endothelial dysfunction have been implicated in NTG in which decreased RBF correlates with increasing optic nerve head (ONH) damage. 4,7 -10 Peripheral blood flow in response to a number of stimuli is impaired in NTG patients-including temperature, 9 postural changes, 11 or chemical response. 8 Vasoactive substances act upon the underlying pericytes of the capillary bed to cause contraction or relaxation. Additionally, pericyte -EC cross-talk through a multitude of factors such as the vasoactive factors described above and others such as angiopoietin, PDGF, TGF-b, and VEGF stabilize capillary endothelial tubes and are critical for microvessel homeostasis. Understanding the effects of haemodynamic regulation of endothelial and pericyte apoptosis and proliferation is critical to understanding the disruption of this homeostatic balance and progression of retinopathies, in which both apoptosis and proliferation are hallmarks of retinal neovessel formation and dysfunction associated with DR.
Perturbations in the microcirculation may be a causative factor of such vascular remodelling that prevails in DR. Retinas from DR patients are highly sensitive to changes in blood glucose levels and systemic hypertension and exhibit impaired flicker-induced vasodilation. 12 -14 Similarly, streptozotocin-induced diabetic rats exhibit impaired RBF auto-regulation. 15 During the latter stages of DR, loss of vessel homeostasis leads to regional vascular changes, with both vessel regression and growth of immature neovessels lacking pericyte coverage, each of which implies an alteration in EC and pericyte cell fate. Using a CELLMAX TM transcapillary in vitro co-culture system, we have previously demonstrated that acute changes in pulsatile flow regulate the activity and expression of the microvascular retinal EC-derived vasoactive mediators NO, PGI 2 , and ET-1. 16 This in vitro co-culture system recapitulates the complex haemodynamic forces the vascular cells are exposed to in vivo-ECs experiencing both shear stress and pulse pressure (cyclic strain) and pericytes exposed to pulse pressure. Additionally, numerous reports have implicated NO, PGI 2 , and ET-1 as important molecules mediating apoptosis in macrovascular cells. As such, in the present study, we have examined whether sustained changes in pulsatile flow control microvascular EC and pericyte cell proliferation and apoptosis through regulation of EC-derived vasoactive mediators.
Methods
An expanded Methods section is provided in the Supplemental material online.
Perfused transcapillary co-cultures
Perfused transcapillary co-cultures of bovine retinal pericyte (BRP) and bovine retinal EC (BREC) were established as described previously. 16 Briefly, cells were exposed to low (0.3 mL/min; 6 mmHg; 0.2 Hz; 0.5 dynes/cm 2 ) and high pulsatile flow (25 mL/min; 56 mmHg; 2 Hz; 23 dynes/cm 2 ) in co-culture for 72 h, before each cell type was harvested separately via trypsinization.
Co-culture inhibitor studies
NOS, COX, and ET receptor activation was repressed using the inhibitors L-NAME (500 mM), indomethacin (100 mM), and PD142893 (1 mM) respectively. L-NAME is a non-selective inhibitor of NOS isoforms, indomethacin is a non-selective COX inhibitor, and PD142893 is an antagonist of both ET-A and ET-B receptor subtypes. Inhibitors were added to circulating media 24 h prior to ramping of flow rates. Cells were harvested for protein, RNA, and FACS analysis and media samples were measured for levels of NO x , PGI 2 , and ET-1.
SNAP, iloprost, and ET-1 treatment
Static cultures of BREC or BRP were quiesced in media containing low FCS (1% FCS) for 24 h prior to the addition of an NO generator: S-nitroso-N-acetylpenicillamine (SNAP, 50 mM); a PGI 2 analogue: iloprost (50 and 500 nM); or an ET-1 peptide (10 and 100 nM) in media containing low serum (1%) for 72 h. Cells were trypsinized for FACS apoptosis analysis.
Statistical analysis
Results are expressed as mean + SD for at least three independent experiments using the perfused transcapillary co-culture system. All other data are the mean + SEM of at least three independent experiments performed in triplicate. Statistical significance was assessed by a Wilcoxon signed-rank test with significance values of P ≤ 0.05.
Results

Pulsatile flow-induced NO x release
We investigated the prolonged effects of 'low' (0.3 mL/min; 6 mmHg; 0.5 dynes/cm 2 ) and 'high' (25 mL/min; 56 mmHg; 23 dynes/cm 2 ) pulsatile flow rates on the phosphorylation of eNOS protein and total eNOS mRNA and protein levels in BREC co-cultured with BRP over a 72 h period. Using western blot analysis, a significant increase in the phosphorylation of eNOS at serine 1179 was detected under high compared with low flow conditions ( Figure 1A ). Total eNOS protein and mRNA levels were also significantly increased following exposure to high flow ( Figure 1B and C ). The increase in eNOS expression was accompanied by a significant increase in basal NO x levels (0.48 + 0.1 -1.34 + 0.17 mM) in conditioned media from cells exposed to high flow conditions ( Figure 1D ).
Pulsatile flow-induced PGI 2 release
Sustained increases in pulsatile flow did not significantly alter BREC or BRP COX-1 protein (Figure 2A and B). Increased pulsatile flow increased BREC COX-2 protein ( Figure 2C ) and mRNA ( Figure 2E ), in the absence of any changes in BRP COX-2 protein ( Figure 2D ). BREC COX-2, but not COX-1 mRNA levels were increased under high flow conditions ( Figure 2E and F). The basal levels of PGI 2 in the conditioned media (5.56 + 1.3 ng/mL) were significantly increased in cells exposed to high compared with low flow ( Figure 2G ). The levels of PGI 2 in mono-cultured BRP was unaffected by changes in pulsatile flow (data not shown).
Pulsatile flow-induced ET-1 release
Increased pulsatile flow significantly decreased BREC pre-pro-ET-1 mRNA levels as determined by RT-PCR ( Figure 3A ), whereas analysis of conditioned media from co-cultures revealed a significant decrease in the circulating ET-1 peptide from basal levels (0.76 + 0.1 ng/mL) ( Figure 3B ). The functional effector response to changes in ET-1 levels was examined by determining the expression levels of ET-A and ET-B receptors in both BREC and BRP via RT-PCR. The level of ET-B receptor expression was enhanced in both BREC and BRP exposed to high flow ( Figure 3C and D), whereas the level of ET-A mRNA in BRP was significantly decreased ( Figure 3E ). ET-A receptor mRNA levels were not detected in BREC (data not shown).
Effect of NOS and COX inhibition and
ET receptor blockade on the flow-induced NO x , PGI 2 , and ET-1 levels
The effect of NOS and COX inhibition and ET receptor blockade on flow-induced NO x and PGI 2 activity was determined using L-NAME (500 mM), indomethacin (100 mM), and PD142893 (1 mM), to block NOS, COX, and ET receptors, respectively. Treatment of co-cultured cells with L-NAME decreased flow-induced NO x release when compared with controls ( Figure 4A ), whereas COX inhibition following indomethacin treatment did not affect nitrate levels under low or high flow conditions ( Figure 4A) . In a similar manner, ET receptor blockade with PD142893 did not affect nitrate levels under either flow condition ( Figure 4A) .
Treatment of co-cultured cells with indomethacin significantly decreased PGI 2 levels under both low and high flow conditions when compared with controls ( Figure 4B ). In contrast, the inhibition of NOS with L-NAME significantly increased PGI 2 under both flow conditions ( Figure 4B ). The inhibition of ET-1 binding in the presence of PD142893 had no significant effect on PGI 2 release at either flow rate ( Figure 4B ). Both L-NAME and indomethacin treatment did not significantly alter ET-1 levels under flow conditions ( Figure 4C ).
Effect of pulsatile flow on endothelial and pericyte cell apoptosis
The prolonged effects of pulsatile flow on BREC and BRP apoptosis were examined after exposure of cells to low and high flow for 72 h. The number of apoptotic BREC (14 + 3%) was significantly reduced at high flow when compared with low flow ( Figure 5A ). The inhibition of NOS, COX, and ET receptors did not affect the number of apoptotic BREC at low flow when compared with untreated controls. In contrast, the inhibition of either NOS, COX, or ET receptors significantly reversed the pro-survival effects of increased pulsatile flow on BREC ( Figure 5A) .
In contrast, the number of apoptotic BRP (10 + 3%) was significantly enhanced at high flow when compared with low flow Figure 1 Pulsatile flow-induced eNOS expression and activity in co-cultured BREC under low and high pulsatile flow conditions. BREC were co-cultured with BRP under low and high flow conditions for 72 h before eNOS phosphorylation (A), total protein (B), steady-state mRNA (C), and nitrate levels (D) were quantified. *P ≤ 0.05 vs. low flow.
( Figure 5A ). The inhibition of NOS increased the number of apoptotic cells under low flow but did not alter BRP apoptosis at high flow ( Figure 5A ). In contrast, the inhibition of both COX and ET receptors significantly attenuated the high flow-induced increase in BRP apoptosis without any significant effect on BRP apoptosis under low flow conditions ( Figure 5A ).
NO, PGI 2 , and ET-1 on cell apoptosis
To investigate the direct effects of NO, PGI 2 , and ET-1 on BREC and BRP apoptosis, static cultures were treated with either an NO generator: SNAP (50 mM); a PGI 2 analogue: iloprost (50 nM and 500 nM); or an ET-1 peptide (10 nM and 100 nM) in media containing low serum. The number of apoptotic cells in both BREC (12 + 2%) and BRP (10 + 2%) was significantly increased under serum-deprived conditions (1% FCS), compared with normal serum controls ( Figure 5B  and C) .
Treatment of BREC with SNAP, ET-1, or iloprost resulted in a significant decrease in apoptosis when compared with untreated controls ( Figure 5B) . Treatment of BRP with ET-1 or iloprost did not significantly alter the level of apoptosis ( Figure 5C ). In contrast, SNAP significantly decreased BRP apoptosis when compared with untreated controls ( Figure 5C ). T.E. Walshe et al.
Effect of pulsatile flow on endothelial and pericyte cell proliferation
Co-cultures of BREC and BRP were grown for 3 or 18 days under low and high pulsatile flow conditions and subsequently analysed using a FACS-based CFDA SE cell tracer proliferation assay. Flow cytometry analysis of BRECs revealed no change in proliferation after 3 or 18 days co-culture with BRPs ( Figure 6A and B) . Western blot analysis of proliferation cell nuclear antigen (pCNA) protein revealed no change in BREC pCNA at high compared with low pulsatile flow after 3-day co-culture ( Figure 6C) .
Flow cytometry analysis of BRP proliferation revealed a slight, but insignificant change after 3 days co-culture with BRECs ( Figure 7A) . BRP proliferation was significantly decreased under high compared with low pulsatile flow conditions after 18-day co-culture ( Figure 7B) . pCNA protein was also significantly decreased after 3-day co-culture at high pulsatile flow ( Figure 7C ).
Discussion
Variations in ocular blood flow have been shown to be a major factor in the pathogenesis of glaucoma. 17, 18 Fluorescein angiography measurements of HTG patients reveal impaired retinal and ONH perfusion and retinal oedema. 18 The putative role of altered RBF is more often described in the pathogenesis of NTG however, since intra-ocular pressure (IOP) measurements are within the normal range and yet, glaucomatous optic neuropathy still occurs. 9, 19 Although RBF is typically decreased in glaucoma, RBF changes are less clear in DR. The diabetic retina progresses through distinct phases of proliferative and nonproliferative disease, each of which can comprise large regional variations in RBF. 20 Not surprisingly, a number of published reports of RBF in DR are often contradictory. For example, pulsatile ocular blood flow is higher in diabetic patients compared with controls and also appears to increase as the severity of retinopathy progresses. 21 In contrast, other studies reveal a non-significant increase in ocular blood flow in mild DR and a significant decrease as the severity of disease increases. 22 More recent studies describe a decrease in arteriole and venule blood flow velocities in patients with non-proliferative DR. 23 In both glaucoma and DR, the effect of these perfusion abnormalities at the cellular level in maintaining microvessel auto-regulation via the release of vasoactive substances is poorly understood.
Measurements of volumetric flow rates in the retinal capillary bed are unreliable at present. As such, the perfusion pressure is often used as a measure of biomechanical strain in the retinal microvasculature. Furthermore, the retinal microvasculature is unique since the perfusion pressure is also dependent upon the IOP. Given a patient's blood pressure and IOP measurements, it is possible to estimate the retinal perfusion pressure. A strong association between DR and increased retinal perfusion pressure has been demonstrated in humans. 24 Further, a seemingly normal blood pressure can combine with a low IOP increasing the retinal perfusion pressure.
In the present study, we have examined the effects of sustained exposure to low and high pulsatile flow rates (and perfusion pressures) on co-cultured ECs and pericytes, as a model of stable vessels in vitro. Previously, we reported the effects of acute changes in pulsatile flow on EC release of vasoactive substances in the absence or presence of pericytes. 16 Pericytes are known to regulate blood flow and contribute to retinal microvessel stability and pericyte apoptosis is a common early feature of DR. 25 After 24 h, pericytes did not significantly alter EC release of NO x , ET-1, or PGI 2 , with increased pulsatile flow leading to enhanced release of NO, PGI2, and ET-1. However, pericytes are known to stabilize endothelial tubes and modulate cell Figure 4 The effect of inhibition of eNOS, COX, and ET-1 with L-NAME, indomethacin, and PD142893, respectively, on flow-induced changes in NO, PGI 2 , and ET-1 levels. Pulsatile flow-induced (A) nitrate level, (B) PGI 2 , and (C) ET-1 in co-cultured BREC under low and high pulsatile flow conditions in the absence or presence of L-NAME, indomethacin, and PD142893. *P ≤ 0.05 vs. low flow, # P ≤ 0.05 vs. high flow control.
T.E. Walshe et al.
health and proliferation through other signalling pathways such as VEGF and TGF-b. Our initial co-cultures of ECs/pericytes could be maintained for up to at least 28 days when exposed to flow (data not shown), which was not possible with mono-cultures or in the absence of flow, suggesting that paracrine signalling between the two cell types could modulate cell health in a haemodynamic environment over time. We therefore sought to examine the effects of sustained alterations in pulsatile flow on release of vasoactive substances and to determine the role and interaction of flow-induced endothelial-derived vasoactive substances in mediating changes in EC and pericyte apoptosis. The present study reveals that 'sustained' increases in pulsatile flow promote EC survival but enhance pericyte apoptosis through the release of specific endothelial-derived vasoactive substances. DR patients with retinal perfusion pressure values .50 mmHg are at greater risk of disease progression. 24 The pulse pressure used in the current study was 56 mmHg and would correlate with these findings since pericyte apoptosis increased at these rates. Our low flow pulse pressure value 6 mmHg is considerably lower than the optimum retinal perfusion pressure of 47 mmHg, possibly explaining why increased EC apoptosis was found with these flow parameters. Microvascular ECs in normal blood vessels produce NO, PGI 2 , and ET-1 which contribute to maintaining vessel homeostasis. 26 We have previously demonstrated the acute effect of pulsatile flow on microvascular ECs and BRP in co-culture, with increased levels of NO x , PGI 2 , and ET-1 released from ECs exposed to increased pulsatile flow independent of the presence or absence of underlying pericytes. 16 We now report the effect of sustained increases in pulsatile flow on BREC/BRP apoptosis in co-culture. Similar to the acute BREC response, a sustained increase in NO x and PGI 2 was evident, due to increased BREC eNOS protein and phosphorylation and also COX-2 protein expression. These results concur with numerous reports of increased NO and PGI 2 upon exposure to increases in shear stress. 27 -29 Flow-induced PGI 2 production is mediated in part by increased arachidonic acid release and altered expression of COX enzymes. 28 We demonstrated a flow-dependent increase in endothelial COX-2, but not COX-1 protein, whereas pericyte COX expression was unchanged. Since PGI 2 levels in mono-cultured BRP exposed to pulsatile flow were negligible compared with co-cultured cells, it is clear that EC through COX-2 are the predominant flow-induced source of PGI 2 .
The bi-phasic ET-1 response to increased flow for macrovascular cells 29 is also apparent for microvascular EC. Although retinal EC can release ET-1 following acute exposure to high flow, 16 sustained exposure results in decreased BREC pre-pro-ET-1 mRNA levels and peptide release. These data suggest a possible mechanism whereby microvessels maintain blood flow at a constant rate, such that acute increases in blood flow stimulate ET-1 release, returning blood flow to 'normal' levels. As increased vascular tissue concentrations of ET-1 can also occur in the absence of changes in plasma concentrations, 30 receptor expression may more reliably reflect the activation of the ET system in vascular cells. For example, plasma ET-1 levels are unaltered among NTG patients compared with controls in the Japanese population, which contains the highest prevalence of NTG; 31 however, polymorphisms in the ET-A gene are associated with NTG. 32 Furthermore, interplay between the vasoactive pathways is important as increased endothelial ET-B receptors can regulate ET-1-mediated eNOS activation. 33 In this context, we and others have shown a flow-dependent up-regulation of ET-B receptors in macrovascular cells. 34 Our current study reveals a similar auto-regulation of ET receptors within microvascular cells.
The opposing vasoactive effects of ET-1 on ET-A or ET-B receptors may also explain the inability of bosentan (a dual ET-A/ET-B receptor Figure 5 Pulsatile flow-induced and vasoactive factor-induced BREC and BRP apoptosis. Co-cultured BREC and BRP were exposed to low and high pulsatile flow conditions for 72 h in the absence or presence of L-NAME, indomethacin, and PD142893 before the number of apoptotic nuclei was determined by FACS analysis (A). *P ≤ 0.05 vs. low flow, # P ≤ 0.05 vs. high flow control. The effect of NO, PGI 2 , and ET-1 on serum deprivation-induced BREC (B) and BRP (C) apoptosis. BREC and BRP were exposed in static cultures to SNAP, iloprost, and ET-1 in 1% FBS before the number of apoptotic nuclei were determined by FACS analysis. *P ≤ 0.05 vs. 10% FCS, # P ≤ 0.05 vs. 1% FCS.
antagonist) to correct the subnormal retinal oxygenation response in diabetic rats. 35 To date, few studies on pericyte -EC interactions have examined the cross-talk regulating cell fate decisions. In the current study, the role of the specific vasoactive mediators in the divergent EC/pericyte apoptotic response to sustained increases in pulsatile flow was also examined. NO is a known anti-apoptotic stimulus in ECs; 36 however, excessive local concentrations can lead to reactive oxygen species, apoptosis, and also necrosis. 37 The increase in BRP apoptosis at high flow was not attributable to NO since L-NAME failed to reverse the flow-induced apoptotic response. In contrast, the inhibition of COX enzymes with indomethacin attenuated the flow-induced increase in apoptosis, suggesting a role for COX products such as PGI 2 in controlling pericyte survival. Interestingly, despite the fact that the PGI 2 analogue, iloprost, induced apoptosis via a cAMP-mediated suppression of ERK activity in vascular smooth muscle cell, 38 it did not inhibit BRP-induced apoptosis following serum deprivation in static cultures, suggesting that another COXdependent product is responsible for the flow-induced increase in BRP apoptosis. Findings from static and flow experiments may diverge as a result of flow modulation of multiple pathways that are both interdependent and often compensatory, as in the case of ET-1 and NO/PGI 2 signalling. 26, 39, 40 Furthermore, the absence of pericyte-derived paracrine signalling in mono-culture static experiments or flow-induced cytoskeletal rearrangement modulation of intracellular signalling pathways may also explain these effects. 41 Lastly, the level of BRP apoptosis was significantly increased following NO inhibition under low flow conditions, concomitant with increased PGI 2 underscoring the importance of the interaction between both systems in these cells. Our data further suggest that flow-induced ET-1 and NO is a prosurvival factor for BREC since preventing ET-1 from binding to ET receptors (primarily ET-B on BREC) or blocking NOS with L-NAME reversed the pro-survival effects of high flow on BREC apoptosis. This is in agreement with reports that ET-1 functions as a survival factor for EC in an autocrine/paracrine manner via the ET-B receptor. 42 Even though ET-1 decreased approximately two-fold at high flow, ET-1 may have an important protective role since BREC ET-B receptor mRNA increased 3-fold at high pulsatile flow. Interestingly, ET-1 induces NO production via the activation of the ET-B receptor and this may present a mechanism by which ET protects BREC exposed to flow. ET-1 also protected BREC from serum deprivation-induced apoptosis, confirming its pro-survival effect in these cells.
In BRP under static and low flow conditions, ET-1 was without any significant effect. In contrast, under high flow conditions, blocking ET-1 binding resulted in a significant decrease in apoptosis. The inhibition of ET-1 peptide function with the mixed ET-A/ET-B antagonist PD142893 did not significantly affect either NO x or PGI 2 levels, suggesting that the ET-1 response was independent of changes in NO x and PGI 2 . Furthermore, NOS and COX inhibition failed to attenuate the flow-induced decrease in ET-1 levels, further reinforcing the likelihood that the ET-1-mediated flow-induced apoptotic response in BRP is NOS-and COX-independent. However, our data may indicate that ET-1 regulates COX activation of other PGs such as PGE 2 , since the inhibition of PGs per se is a pro-survival stimulus for these cells. Vascular proliferation is a critical feature of the retinal microvascular dysfunction in DR, in which endothelial proliferation occurs after pericyte apoptosis. Loss of pericytes is postulated as an absence of an anti-proliferative stimulus for ECs. Vessel proliferation in the retinal space also occurs in the proliferative phase of age-related macular degeneration; however, these vessels derive from the choroidal circulation. Previous studies have described an important role for flow-induced modulation of endothelial proliferation, dependent upon the distinct pattern to which ECs are exposed. 43 In the current study, altered pulsatile flow was surprisingly ineffective at altering endothelial proliferation rates, demonstrating that the presence of pericytes alone is sufficient to arrest EC cycling. In contrast, biomechanical stress in the microvessel wall decreases pericyte proliferation at the higher flow rates, concomitant with increased apoptosis. These findings demonstrate a key role for both paracrine signalling and mechanical forces in neovessel formation in vivo.
In summary, we have demonstrated that microvascular retinal ECs respond to sustained changes in flow by altering the release of endothelial-derived vasoactive substances that control endothelial and pericyte apoptosis. Since increased pulsatile flow is protective to ECs, reduced ocular blood flow in glaucoma may result in increased EC apoptosis, further impairing optic nerve and retinal perfusion. In contrast, increased pericyte apoptosis at higher flow rates may be of particular relevance to early non-proliferative DR, where increased RBF might contribute to pericyte apoptosis-one of the earliest histopathological features of DR. These data also suggest that significant paracrine regulatory mechanisms exist within the microvascular environment. Nowhere are these interactions more important than in the retinal microcirculation where auto-regulation is vital for the maintenance of uninterrupted blood flow to the metabolically active retinal tissue. The potential role of these interactions in the pathogenesis of retinopathies will also prove invaluable in the treatment of these conditions. Figure 7 Pulsatile flow-induced BRP proliferation in co-culture with BRECs. BRP proliferation was unchanged from low (green) compared with high (red) pulsatile flow after 3-day co-culture with BRPs (A). After 18-day co-culture (B), BRP proliferation was significantly decreased under high flow conditions. BRP pCNA protein levels decreased at high compared with low pulsatile flow after 3-day co-culture with BRECs (C).
